These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Key gp120 Glycans Pose Roadblocks to the Rapid Development of VRC01-Class Antibodies in an HIV-1-Infected Chinese Donor. Kong L; Ju B; Chen Y; He L; Ren L; Liu J; Hong K; Su B; Wang Z; Ozorowski G; Ji X; Hua Y; Chen Y; Deller MC; Hao Y; Feng Y; Garces F; Wilson R; Dai K; O'Dell S; McKee K; Mascola JR; Ward AB; Wyatt RT; Li Y; Wilson IA; Zhu J; Shao Y Immunity; 2016 Apr; 44(4):939-50. PubMed ID: 27067056 [TBL] [Abstract][Full Text] [Related]
6. Inference of the HIV-1 VRC01 Antibody Lineage Unmutated Common Ancestor Reveals Alternative Pathways to Overcome a Key Glycan Barrier. Bonsignori M; Scott E; Wiehe K; Easterhoff D; Alam SM; Hwang KK; Cooper M; Xia SM; Zhang R; Montefiori DC; Henderson R; Nie X; Kelsoe G; Moody MA; Chen X; Joyce MG; Kwong PD; Connors M; Mascola JR; McGuire AT; Stamatatos L; Medina-RamÃrez M; Sanders RW; Saunders KO; Kepler TB; Haynes BF Immunity; 2018 Dec; 49(6):1162-1174.e8. PubMed ID: 30552024 [TBL] [Abstract][Full Text] [Related]
7. Toward a more accurate view of human B-cell repertoire by next-generation sequencing, unbiased repertoire capture and single-molecule barcoding. He L; Sok D; Azadnia P; Hsueh J; Landais E; Simek M; Koff WC; Poignard P; Burton DR; Zhu J Sci Rep; 2014 Oct; 4():6778. PubMed ID: 25345460 [TBL] [Abstract][Full Text] [Related]
8. N332-Directed broadly neutralizing antibodies use diverse modes of HIV-1 recognition: inferences from heavy-light chain complementation of function. Pancera M; Yang Y; Louder MK; Gorman J; Lu G; McLellan JS; Stuckey J; Zhu J; Burton DR; Koff WC; Mascola JR; Kwong PD PLoS One; 2013; 8(2):e55701. PubMed ID: 23431362 [TBL] [Abstract][Full Text] [Related]
9. HIV-1 receptor binding site-directed antibodies using a VH1-2 gene segment orthologue are activated by Env trimer immunization. Navis M; Tran K; Bale S; Phad GE; Guenaga J; Wilson R; Soldemo M; McKee K; Sundling C; Mascola J; Li Y; Wyatt RT; Karlsson Hedestam GB PLoS Pathog; 2014 Aug; 10(8):e1004337. PubMed ID: 25166308 [TBL] [Abstract][Full Text] [Related]
10. HIV-1 fitness cost associated with escape from the VRC01 class of CD4 binding site neutralizing antibodies. Lynch RM; Wong P; Tran L; O'Dell S; Nason MC; Li Y; Wu X; Mascola JR J Virol; 2015 Apr; 89(8):4201-13. PubMed ID: 25631091 [TBL] [Abstract][Full Text] [Related]
11. Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires. Tian M; Cheng C; Chen X; Duan H; Cheng HL; Dao M; Sheng Z; Kimble M; Wang L; Lin S; Schmidt SD; Du Z; Joyce MG; Chen Y; DeKosky BJ; Chen Y; Normandin E; Cantor E; Chen RE; Doria-Rose NA; Zhang Y; Shi W; Kong WP; Choe M; Henry AR; Laboune F; Georgiev IS; Huang PY; Jain S; McGuire AT; Georgeson E; Menis S; Douek DC; Schief WR; Stamatatos L; Kwong PD; Shapiro L; Haynes BF; Mascola JR; Alt FW Cell; 2016 Sep; 166(6):1471-1484.e18. PubMed ID: 27610571 [TBL] [Abstract][Full Text] [Related]
12. Antibodies VRC01 and 10E8 neutralize HIV-1 with high breadth and potency even with Ig-framework regions substantially reverted to germline. Georgiev IS; Rudicell RS; Saunders KO; Shi W; Kirys T; McKee K; O'Dell S; Chuang GY; Yang ZY; Ofek G; Connors M; Mascola JR; Nabel GJ; Kwong PD J Immunol; 2014 Feb; 192(3):1100-1106. PubMed ID: 24391217 [TBL] [Abstract][Full Text] [Related]
13. Selection pressure on HIV-1 envelope by broadly neutralizing antibodies to the conserved CD4-binding site. Wu X; Wang C; O'Dell S; Li Y; Keele BF; Yang Z; Imamichi H; Doria-Rose N; Hoxie JA; Connors M; Shaw GM; Wyatt RT; Mascola JR J Virol; 2012 May; 86(10):5844-56. PubMed ID: 22419808 [TBL] [Abstract][Full Text] [Related]
14. Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection. Wu X; Zhang Z; Schramm CA; Joyce MG; Kwon YD; Zhou T; Sheng Z; Zhang B; O'Dell S; McKee K; Georgiev IS; Chuang GY; Longo NS; Lynch RM; Saunders KO; Soto C; Srivatsan S; Yang Y; Bailer RT; Louder MK; ; Mullikin JC; Connors M; Kwong PD; Mascola JR; Shapiro L Cell; 2015 Apr; 161(3):470-485. PubMed ID: 25865483 [TBL] [Abstract][Full Text] [Related]
15. Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo. Rudicell RS; Kwon YD; Ko SY; Pegu A; Louder MK; Georgiev IS; Wu X; Zhu J; Boyington JC; Chen X; Shi W; Yang ZY; Doria-Rose NA; McKee K; O'Dell S; Schmidt SD; Chuang GY; Druz A; Soto C; Yang Y; Zhang B; Zhou T; Todd JP; Lloyd KE; Eudailey J; Roberts KE; Donald BR; Bailer RT; Ledgerwood J; ; Mullikin JC; Shapiro L; Koup RA; Graham BS; Nason MC; Connors M; Haynes BF; Rao SS; Roederer M; Kwong PD; Mascola JR; Nabel GJ J Virol; 2014 Nov; 88(21):12669-82. PubMed ID: 25142607 [TBL] [Abstract][Full Text] [Related]
16. Sequence intrinsic somatic mutation mechanisms contribute to affinity maturation of VRC01-class HIV-1 broadly neutralizing antibodies. Hwang JK; Wang C; Du Z; Meyers RM; Kepler TB; Neuberg D; Kwong PD; Mascola JR; Joyce MG; Bonsignori M; Haynes BF; Yeap LS; Alt FW Proc Natl Acad Sci U S A; 2017 Aug; 114(32):8614-8619. PubMed ID: 28747530 [TBL] [Abstract][Full Text] [Related]
17. Study of antibody repertoires to the CD4 binding site of gp120 of a Chinese HIV-1-infected elite neutralizer, using 454 sequencing and single-cell sorting. Li D; Wang Z; Ren L; Zhang J; Feng G; Hong K; Hao Y; Qi Z; Liang H; Shao Y Arch Virol; 2016 Apr; 161(4):789-99. PubMed ID: 26671829 [TBL] [Abstract][Full Text] [Related]
18. Overcoming Steric Restrictions of VRC01 HIV-1 Neutralizing Antibodies through Immunization. Parks KR; MacCamy AJ; Trichka J; Gray M; Weidle C; Borst AJ; Khechaduri A; Takushi B; Agrawal P; Guenaga J; Wyatt RT; Coler R; Seaman M; LaBranche C; Montefiori DC; Veesler D; Pancera M; McGuire A; Stamatatos L Cell Rep; 2019 Dec; 29(10):3060-3072.e7. PubMed ID: 31801073 [TBL] [Abstract][Full Text] [Related]
19. Characterization of a VRC01-like antibody lineage with immature V Hu Y; Li D; Yuan Z; Feng Y; Ren L; Hao Y; Wang S; Hu X; Liu Y; Hong K; Shao Y; Wang Z Mol Immunol; 2023 Feb; 154():11-23. PubMed ID: 36577292 [TBL] [Abstract][Full Text] [Related]
20. Mouse marginal zone B cells harbor specificities similar to human broadly neutralizing HIV antibodies. Pujanauski LM; Janoff EN; McCarter MD; Pelanda R; Torres RM Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1422-7. PubMed ID: 23288906 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]